Mitochondrial Neuropathies are a group of neurological disorders caused by mutations in the mitochondrial DNA. These disorders can affect the central nervous system, peripheral nervous system, and muscles. Symptoms can include muscle weakness, fatigue, vision and hearing loss, seizures, and learning disabilities. Diagnosis is based on clinical presentation, family history, and laboratory tests. Treatment is focused on managing symptoms and preventing further damage.
The Mitochondrial Neuropathies market is a growing segment of the Neurology market. Companies in this market are focused on developing treatments and therapies to improve the quality of life for those affected by these disorders. Some of the companies in this market include BioMarin Pharmaceuticals, Inc., Ultragenyx Pharmaceutical, Inc., and Sanofi Genzyme. Show Less Read more
